On October 6, 2014 new federal regulations on drugs that contain hydrocodone will take effect. Under the new ruling, hydrocodone combination products (HCPs) will be reclassified from Schedule III to the more restrictive Schedule II. More than 60 different products will be affected by this ruling. Two of the most familiar brand names are Vicodin... Read more
September is Pain Awareness Month and a number of chronic pain organizations are sponsoring events and activities to help spread the word about chronic pain and the toll it takes on the lives of those who suffer with it.
There was a time – not too long ago – when people living with chronic pain were pretty much on their own.... Read more
The U.S. Drug Enforcement Administration (DEA) has officially designated tramadol as a Schedule IV substance under the Controlled Substance Act, effective August 18, 2014. On the federal level, until this action, tramadol was an unscheduled prescription medication. However, a number of states had already proactively reclassified it as a controlled... Read more
Two years ago the University of Maryland conducted a chronic pain study, which some of you took part in. Now they are conducting another online study for caregivers and have invited our chronic pain community to participate.
The purpose of the study is to learn more about the experiences and needs of caregivers, who are often overlooked. If... Read more
As most chronic pain patients are well aware, both federal and state governments across the U.S. are looking for ways to curb prescription drug abuse. While their motives may be noble, sometimes their actions have unintended consequences. Too often laws intended to make it more difficult for abusers to gain access to narcotics end up also making... Read more